Dr. Vikash Oza, MD

Dr. Vikash Oza, MD is a dermatologist in New York, New York with 18 years of experience. Public disclosure records include several professional activity categories, including consulting fees, honoraria, and travel and lodging, involving pharmaceutical companies and dermatology-focused pharmaceutical companies.

What is your opinion of Dr. Vikash Oza, MD? Rate this provider below so other people can make informed decision.

English

Based on the training and education, Dr. Vikash Oza, MD may treat patients with the following conditions. Please always check with Dr. Vikash Oza, MD directly about which exact conditions he treats.

Based on the training and education, Dr. Vikash Oza, MD may perform the following treatments. Please always check with Dr. Vikash Oza, MD directly about which exact treatments he offers.

(These can include payments from pharmaceutical companies, medical device companies, and other companies.)

Dr. Vikash Oza, MD has received over $85,472 in payments from medical companies (41% more than the average Dermatologist in New York, NY)

PFIZER INC. - $1,496.66 payment for Consulting Fee on 11/12/2024

Incyte Corporation - $2,100.00 payment for Consulting Fee on 09/18/2024

LNHC, Inc - $2,275.00 payment for Honoraria on 07/11/2024

LEO Pharma Inc. - $25.00 payment for Education on 05/10/2024

E.R. Squibb & Sons, L.L.C. - $33.13 payment for Food and Beverage on 01/23/2024

Incyte Corporation - $14.97 payment for Food and Beverage on 12/01/2023

Incyte Corporation - $79.59 payment for Travel and Lodging on 12/01/2023

Incyte Corporation - $158.46 payment for Travel and Lodging on 12/01/2023

Incyte Corporation - $437.79 payment for Travel and Lodging on 12/01/2023

Incyte Corporation - $73.17 payment for Travel and Lodging on 12/01/2023

Dr. Vikash Oza is generally seen as a knowledgeable, compassionate physician whose strongest reputation rests on careful explanation and hands-on involvement in treatment, though the commentary also includes a pointed allegation about access and records. Praise centers on diagnostic skill and a willingness to coordinate a child's care over the long term, including an honest explanation of a rare disorder followed by sustained management of follow-up needs. Other commentary describes unhurried visits in which specific skin concerns and treatment options were discussed at length, and a helpful outcome for a child with severe eczema after a suitable cream was identified. Warmth toward young patients and a patient, detailed style of explanation also come through. The main criticism is an allegation that the office declined to see a child during a medical emergency, offering a wait of several weeks instead, and refused to release records needed for a new physician, conduct described as unkind. Those concerns bear on access and administration rather than clinical judgment, and they stand apart from the favorable remarks about the doctor's own manner.